IRWD
Ironwood Pharmaceuticals, Inc. · Healthcare
CMO,SVP,Head-Res, Drug Michael Shetzline sold $104K of Ironwood Pharmaceuticals, Inc.
Sold$104,479
$10.12Price
10,324Shares
−3%Stake
What IRWD did after the filing
- The stock from Wed, May 24 close, $10.81
- −5.2%
- S&P 500, same days
- +7.3%
Measured over 30 trading days, to the Jul 10 close.
Traded Mon, May 22. Filed Wed, May 24, 12:05 PM ET, during the session. Returns use the May 24 close and the Jul 10 close. Not investment advice.